{"id":"W3047382221","doi":"10.1016/j.euo.2020.07.002","title":"Phase I/II Trial of the Combination of 177Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN)","year":2020,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cabazitaxel; Prostate cancer; Enzalutamide; Taxane; Urology; Docetaxel; Adverse effect; Prostate-specific antigen; Internal medicine; Oncology; Cancer; Surgery; Androgen deprivation therapy; Breast cancer; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006386561,0.0002104888,0.0006228079,0.0001391307,0.00009579471,0.000007879085,0.00015833,0.00005551069,0.0001305051],"category_scores_gemma":[0.00006756331,0.0001362576,0.00005889991,0.0003761979,0.0007637133,0.00008460262,0.0001253488,0.0003415893,0.000003659396],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009301474,"about_ca_system_score_gemma":0.0005953324,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009753203,"about_ca_topic_score_gemma":0.0001231032,"domain_scores_codex":[0.997523,0.0008334731,0.0006098278,0.0004175416,0.0002703991,0.0003458051],"domain_scores_gemma":[0.9989318,0.0001313944,0.0003974507,0.0002510443,0.0001575494,0.0001307314],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.484744,0.008677803,0.01223129,0.0009109307,0.00107651,0.002271764,0.03270534,0.0003259757,0.4327577,0.001104148,0.001602209,0.02159237],"study_design_scores_gemma":[0.6519966,0.1438088,0.07066877,0.0001742604,0.0007130052,0.0001297087,0.002490404,0.001175098,0.07255579,0.0001084334,0.05563194,0.0005472096],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9809606,0.001004905,0.000009816006,0.01146594,0.0001068315,0.002406819,0.0001445984,0.00001887386,0.00388161],"genre_scores_gemma":[0.9973072,0.001206036,0.00013446,0.0002828502,0.00005871537,0.00007155004,0.00007216692,0.00003696201,0.0008300645],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3602019,"threshold_uncertainty_score":0.5556424,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0444505241222058,"score_gpt":0.3321962393330813,"score_spread":0.2877457152108756,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}